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Gene expression regulation in Leishmania has been related to post-transcriptional events involving
mainly sequences present in the 50 and 30 untranslated regions. PABPs are high-afﬁnity poly(A)-
binding proteins that are implicated in the regulation of translation initiation, RNA stability and
other important biological processes. We describe a PABP from Leishmania infantum (LiPABP) that
shows a very high homology with PABPs from other eukaryotic organisms, including mammals and
other parasites. LiPABP conserves the main domains present in other PABPs, maintains poly(A)-
binding properties and is phosphorylated by p38 mitogen-activated protein kinase. Using the sera
from dogs infected with L. infantum, we demonstrate that LiPABP is expressed in L. infantum
promastigotes.
 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction for RNA recognition, but is necessary for interaction with factorsThe poly(A)-binding protein (PABP) of eukaryotes binds the 30
end poly(A) tail of the mRNAs and participates in different cellular
processes such as translational initiation and termination and in
mRNA turnover [1–3]. When bound to the poly(A) tail, PABP circu-
larizes mRNA molecules via its interaction with translational initi-
ation factors at the cap, enhancing translational initiation and
stabilizing mRNA [1–3]. In addition, interaction with the release
factor eRF3 and dissociation of PABP from the poly(A) tail is neces-
sary for progressive deadenylation and consequent decay for many
transcripts [4–7]. Furthermore, this protein seems to be involved in
mRNA transport from the nucleus to the cytoplasm [1,8].
PABPs interact with poly(A) via RNA-recognition motifs (RRMs)
that appear to be present in proteins in all types of organisms, sug-
gesting that this is an ancestral motif with important functions in
RNA biology. On the other hand, the C-terminal region of PABP
contains an highly conserved carboxy-terminal helical domain
named MLLE, previously known as PABC [9], that is not requiredchemical Societies. Published by E
gen-activated protein kinase;
n motif; SDS–PAGE, sodium
UTR, untranslated region; VL,
ímica-Investigación, Hospital
drid, Spain. Fax: +34 91 336
ín).such as the release factor eRF3 [4] and the PABP-interacting pro-
teins Paip1 and Paip2 [10]. Finally, it exits a proline and gluta-
mine-rich region that connect the RRMs to the MLLE domain that
is implicated in the interaction between different PABP molecules
binding the poly(A) tail [11]. This region, the least conserved seg-
ment of the protein, also contains arginine residues that are target
for the arginine methyl transferase PRMT4/CARM1.
Leishmania is a parasitic protozoan of the trypanosomatids fam-
ily that possesses a digenetic life cycle with two discrete morpho-
logical phases: the promastigote, which develops extracelullarly
within the gut of the insect vector, and the amastigote that is spe-
cialized to survive within the macrophage’s phagolysosome of the
vertebrate host. It is assumed that trypanosomatids parasites need
a regulated expression of stage-speciﬁc genes to survive extreme
environmental changes in which PABP regulation could play some
role.
Different PABPs have been described in trypanosomatids. The
ﬁrst PABP homologue reported in this family was in Trypanosoma
cruzi (TcPABP1) [12]. Afterwards, a Trypanosoma brucei orthologue
86.4% identical to the T. cruzi protein was characterized [13]. Next,
a Leishmania major PABP1 (LmPABP1), only 35% identical to either
of the Trypanosoma PABP homologues, has been found [11]. This
low level of identity could indicate that this protein is not the
homologue of the Trypanosoma PABP. Finally, an in silico analysis
of a putative PABP from Leishmania amazonensis (LaPABP) has been
reported [14]. In this paper we described the ﬁrst PABP homologuelsevier B.V. All rights reserved.
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main domains present in other PABPs and maintains poly(A) bind-
ing properties. Moreover, we demonstrate the presence of LiPABP
in L. infantum promastigotes.2. Materials and methods
2.1. Cell culture and extract preparation
L. infantum (MCAN/ES/96/BCN150) promastigotes were grown
at 26 C in RPMI 1640 medium (PAA Laboratories), supplemented
with 10% (v/v) foetal calf serum (PAA Laboratories), 10 U/ml peni-
cillin and 100 lg/ml streptomycin (Gibco) and lysated in ice-cold
buffer A (20 mM Tris–HCl, pH 7.6, 1 mM dithiothreitol (DTT),
1 mM EDTA, 1 mM phenylmethanesulfonyl ﬂuoride (PMSF),
1 mM benzamidine, 2 mM sodium molybdate, 2 mM sodium b-
glycerophosphate, 0.2 mM sodium orthovanadate, 120 mM KCl,
1 lg/ml leupeptin and pepstatin A, and 10 lg/ml antipain) contain-
ing 1% Triton
X-100 and then centrifuged at 17 000g for 20 min. Protein deter-
mination was performed by the Bradford method [15].
2.2. Sequence alignment, domain assignment and homology modelling
of LiPABP
Homologous sequence to higher eukaryotic of LiPABP
(XP_001469222/LinJ35.4250) was deduced from the Leishmania
genome database (LeishDB; www.sanger.ac.uk), using as query
the sequence of the human protein. Determination of LiPABP se-
quence, molecular weight and isoelectric point were done with
the ExPasy program (www.espasy.ch), and conserved domains
determining was performed with SMART program (http://smar-
t.embl-heidelberg.de/). The PABPs sequence alignment analysis
was produced with CLUSTALW2 program. The structural character-
ization was obtained by CPH models and the homology modelling
was performed using the SWISS-MODEL tool that enables an
automated comparative protein modelling. Finally, the potential
functional sites were identiﬁed with ELM server (http://
elm.eu.org/news.html).
2.3. Cloning and plasmid construction
The L. infantum PABP coding sequence was PCR ampliﬁed from
genomic DNA of L. infantum parasites. The oligonucleotides For-
ward, 50-CGGGATCCATGGCCTTCACTGGTCCGAATC-30 and Reverse,
50-CGGGATCCTCA AACGCTCATG-30, designed from LinJ35.4250 se-
quence, were used. BamHI restriction sites included in the primers
to facilitate cloning are underlined. The resultant PCR product was
inserted into pBluescript II SK (Stratagene). LiPABP was introduced
into the XbaI/EcoRI site of the eukaryotic expression plasmid
pcDNA3-myc to produce the fusion protein myc-LiPABP. LiPABP
was cloned into the BamHI site of pQE30 (Qiagen) to obtain
6HIS-LiPABP recombinant protein (rLiPABP). The constructs were
analyzed by sequencing.
2.4. Expression and puriﬁcation of recombinant LiPABP
Recombinant LiPABP was expressed in M15[pREP4] Escherichia
coli strain cells (Qiagen) and puriﬁed from inclusion bodies as
indicated in Ramos et al. [16]. Fractions were collected and the
presence of LiPABP was analyzed by sodium dodecyl sulphate–
polyacrylamide gel electrophoresis (SDS–PAGE) and silver stain.
The fractions containing LiPABP were pooled and concentrated
and aliquots were stored at 80 C. Protein determination was per-
formed as above.2.5. Cell culture and transient transfections
Transient transfections with pcDNA3-myc-LiPABP were essen-
tially performed as described previously [17]. After the time of
transfection the medium was removed and the cells washed
twice with ice-cold buffer A as above and lysed in the same buffer
containing 1% Triton X-100 (50 ll/106 cells). Cell lysates were
centrifuged at 12 000g for 15 min and the supernatants were
kept at 80 C until used. Protein determination was performed
as above.
2.6. Western blot analysis
Samples were subjected to SDS–PAGE, transferred onto PVDF
membranes (GE Healthcare), incubated with the primary antibod-
ies indicated in Figure legends and later with the secondary perox-
idase-conjugated antibodies (GE Healthcare) and developed with
ECL reagent (GE Healthcare). Stained bands were scanned and
quantiﬁed with an analyzer equipped with the Image QuantTL soft-
ware package (GE Healthcare).
2.7. ELISA assays and anti-LiPABP antibody puriﬁcation
Serum samples, generously provided by Dr. Carlos Gómez Nie-
to, were collected from 25 dogs suffering symptomatic canine vis-
ceral leishmaniasis (VL) and control sera were obtained from
three healthy animals. All sera were positive when were tested
by indirect immunoﬂuorescence as described [18]. In the ELISA
assays, 96-well Maxisorp plates (Nunc) were coated with 100 ll
of the LiPABP recombinant protein (2 lg/ml) in phosphate saline
buffer (PBS) for 18 h at 4 C and processed as previously described
[19].
Speciﬁc antibodies against L. infantum PABP were afﬁnity-
puriﬁed from a pool of four positive anti-PABP sera. For that
purpose 0.7 mg of the rLiPABP was covalently bound to cyanogen
bromide (CNBr)-activated Sepharose 4B (GE Healthcare) and
packed into a column. Coupling and blocking were carried out
according to the manufacturer’s instructions. One ml of the mixed
sera was passed through the antigen column. After washing, the
speciﬁc antibodies were eluted from the column with 0.1 M
glycine, pH 2.8 and equilibrated to pH 7.5 with 1 M Tris–HCl. The
solution of antibodies was restored to the original volume of the
pooled sera.
2.8. Cell-free protein expression
TNT Quick Coupled Transcription/Translation System based on
rabbit reticulocyte lysates (Promega) was used as recommended
in the manufacturer’s instructions. Brieﬂy, 500 ng of pcDNA3-
myc-LiPABP plasmid was added to the mix reaction and incubated
for 30 min at 30 C. Five micro liters of the mix were loaded in a
10% SDS–PAGE gel.
2.9. Poly(A) activity assay
First, poly(A)-Sepharose was formed by the covalent coupling of
poly(A) (Invitrogen) to CNBR-Sepharose 4B following the manufac-
turer instructions (GE Healthcare). To determine the capacity/abil-
ity of LiPABP for binding poly(A), 100 lg of lysates from L. infantum
promastigotes or 25 lg of lysates from HEK293T cells expressing
myc-LiPABP, in 200 ll of binding buffer (20 mM Tris–HCl, pH 7.4,
1 mM DTT, 1 mM MgCl2, 5 mM EDTA and 1 mM PMSF), were incu-
bated with 50 ll of poly(A)-Sepharose (50%) for 1 h at 4 C in the
absence or the presence of 25 lg of poly(A) or poly(U). The beads
were washed three times with binding buffer and proteins were
eluted with Loading/Sample buffer.
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Recombinant LiPABP protein (2 lg) was incubated in the ab-
sence or the presence of 6.25 ng of eukaryotic recombinant p38Fig. 1. Clustering of representative PABPs sequences from different species. The
tree was obtained from the alignment of the sequences in ClustalW2 and displayed
with the program MEGA4. The scale bar indicates 0.1 substitutions per site. Tc, T.
cruzi; Tb, T. brucei; Lm, L. major; Li, L. infantum; h, human. References are in
parenthesis.
Fig. 2. Comparison between human PABP and LiPABP. (A) ClustalW2 alignment comp
motives RNP1 and RNP2 in the RRMs domains are highlighted in blue and violet, respectiv
for RNA binding. The conserved octomeric sequence located in the C-terminal domain is
Theoretical model of the RRM I and RRM II domains showing RNP1 and RNP2 coloured as
RRM domain. (C) Structure of the C-terminal domain of LiPABP showing the conserved
Swiss-PDB Viewer.mitogen-activated protein kinase (MAPK) (Upstate) in kinase buf-
fer containing 30 lM ATP and 3 lCi of [c-32P] ATP (Hartmann Ana-
lytic) at 30 C for 20 min. Kinase reactions were stopped by mixing
with Loading/Sample buffer, subjected to 10% SDS–PAGE and auto-
radiography or visualized using a Typhoon 9400 Phosphorimager
(GE Healthcare).
3. Results and discussion
The poly(A)-binding protein with homology to human PABP
from L. infantum, named LiPABP, was obtained from a L. infantum
genomic library. A single 1770 pb product was cloned and se-
quenced. The reading frame results in a protein containing 585
amino acids, an expected molecular weight of 65 kDa and a basic
theoretical isoelectric point of 9.14. The analysis of the deduced
amino acid sequence and the alignment of this sequence with
those of PABPs from human and other trypanosomatids showed
high identity with some of them. Thus LiPABP is approximately
70% identical to the PABPs from T. cruzi [12] and T. brucei [13]
but only has a 33% of identity to LmPABP1 [11]. During the review
of this paper, two other PABPs from L. major have been character-
ized [20]. One of them, named LmPABP2, could be the orthologue of
LiPABP (95% identical). Phylogenetic and molecular evolutionary
analyses of all PABPs human and trypanosomatids were conductedaring the PABPs sequences from H. sapiens and L. infantum. The highly conserved
ely, and the MLLE domain in green. Asterisk indicated conserved residues important
highlighted in yellow. The residues implicated in methylation are shown in grey. (B)
in A. The secondary structure shown at the top of the ﬁgure corresponds to a single
octomeric sequence in yellow. Figures were prepared using the software package
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same branch that the recently published LmPABP2 and both come
from a common branch shared with TbPABP1 and TcPABP1.
LiPABP sequence conserves the four characteristic RRMs, lo-
cated in the positions 9–81 (RRM1); 96–169 (RRM2); 184–263
(RRM3); 287–364 (RRM4), the C-terminal domain, located in the
positions 509–579, and the sequence between the N-terminal
RRMs and the C-terminal domain that contains only a 10% of pro-
line, but is rich in glycine residues (19%) (Fig. 2A). It has been pre-
viously described that the ﬁrst two RRMs are sufﬁcient for speciﬁc
poly(A) binding [23] and RRMs 3 and 4, lacking poly(A)-binding
speciﬁcity, may mediate recognition of AU-rich elements (ARE)
motifs implicated in mRNA stability present in the 30 untranslated
region of many mRNAs [24]. The structure of the domains of the
human PABPC2 shows that the RRMs are globular domains com-
posed of a four-stranded anti-parallel b sheet backed by two a heli-
ces [22]. The central two b strands of each RRM include two highly
conserved sequence motifs, RNP1 and RNP2. We have generated a
theoretical three-dimensional model of LiPABP that show the four
anti-parallel strands forming the b-sheet responsible for the RNA
binding and two hydrophobic a-helices in the opposite face
(Fig. 2B). Finally, it has been also described that the globular C-ter-
minal domain of PABPs from Homo sapiens [10] and T. cruzi [25]
contains ﬁve a helices. However, LiPABP shows only four a helices
in this region, as described for the MLLE domain from Saccharo-
myces cerevisiae [26], probably due to the fusion of helices 1 andFig. 3. Endogenous LiPABP is expressed in L. infantum promastigotes. (A) ELISA reactivity
against recombinant LiPABP. Solid lines, mean values (b, P < 0.01). The U-Mann–Whitney
(B) 25 lg of lysate from HEK293T cells and 1 lg of recombinant LiPABP were blotted with
ECL system. After washing, the membrane was reprobed with a commercial human anti-
cytoplasmic levels of LiPABP. Different amounts of recombinant LiPABP (12.5–100 ng)
antibodies and developed as above. The bands were quantiﬁed and the values obtained2 (Fig. 2C). Moreover, the motif KITGMLLE located in helix 3 de-
scribed in human PABP [9,10] and that is involved in the interac-
tion with regulatory proteins and translation factors containing a
peptide named PAM2, is also conserved in LiPABP.
Different Leishmania intracellular proteins are antigenic in hu-
man and dogs suffering VL, including the eIF4A translation initia-
tion factor [27]. Thus, we next performed ELISA experiments to
analyze the immunoreactivity of sera from dogs with symptomatic
canine VL against LiPABP. Results indicated that LiPABP is recog-
nized by the immune system of the vertebrate host, since 100%
of the dogs with symptomatic canine VL showed absorbance values
above the negative sera (Fig. 3A). We used the four most antigenic
sera to obtain a puriﬁed anti-LiPABP serum that was able to recog-
nize the recombinant LiPABP but not the endogenous PABP pre-
sents in HEK293T cells (Fig. 3B), indicating that the immune
response is speciﬁcally elicited against the LiPABP as also occurs
with other conserved parasite intracellular antigens. In addition,
the serum detected a band of approximately 65 kDa in lysates from
L. infantum promastigotes corresponding to endogenous LiPABP
(Fig. 3C). We have also used this serum to quantify the cytoplasmic
levels of LiPABP. The results indicated the presence of 2.5 ng of
LiPABP per microgram of protein in lysates from stationary cul-
tures containing 107 promastigotes/ml (Fig 3C).
To conﬁrm the function of LiPABP as a poly(A) binding pro-
tein we performed in vitro binding assay in which lysates from
L. infantum promastigotes were incubated with poly(A)-Sephar-of sera from dogs diagnosed of canine visceral leishmaniosis (VL) and control sera
test was used to analyze the data of the sera from symptomatic and control animals.
the anti-LiPABP antibodies puriﬁed from canine VL sera (1/100) and developed with
PABP antibody (Cell signaling; 1/1000) and developed as above. (C) Quantitation of
and two amounts of total proteins (25 and 50 lg) were blotted with anti-LiPABP
for cytoplasmic protein extrapolated.
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petitors. Endogenous LiPABP bound to the resin was analyzed by
Western blot with the puriﬁed dog anti-LiPABP serum. As shown
in Fig. 4A, the amount of LiPABP bound to poly(A)-Sepharose de-
creased signiﬁcantly (around 20%) in the presence of free
poly(A). However, the addition of poly(U) did not appreciably
decrease the amount of LiPABP bound to poly(A)-Sepharose. To
reinforce this result we have also performed the same experi-
ments with lysates from HEK293T cells expressing myc-LiPABP.
As shown in Fig. 4B, the band (70 kDa) corresponding to LiPABP
bound to poly(A)-Sepharose decreased 75% in the presence of
poly(A) meanwhile poly(U) did not produce any effect. Unex-
pectedly, the anti-myc antibody also detected a second band
(50 kDa) corresponding to other form of the protein that also
bound poly(A) with the same afﬁnity. Both two bands were also
obtained using other human cell lines such as MCF7 or HepG2
(data not shown). However, only the upper band was producedFig. 4. LiPABP maintains poly(A)-binding activity and is phosphorylated by p38 MAPK. R
expressed in HEK293T cells (B) bound to poly(A)-Sepharose in the presence or not o
corresponding to 50 lg of L. infantum lysate or 10 lg of lysate from cells expressing myc
the values normalized relative to the LiPABP bound in the absence of competitor. Bars
**P < 0.001. (C) Five micro liters of the reaction mixture containing myc-LiPABP transcrib
diluted 1/1000. A reaction without plasmid was used as a control. 10 lg of lysate from
same gel. (D) Recombinant p38 MAPK was used to phosphorylate LiPABP in an in vitro
Phosphorylation of the myelin basic protein (MBP) by p38 MAPK was used as a positive
reported by ELM database software, is shown at the bottom of the ﬁgure. An asterisk mwhen the plasmid containing LiPABP was transcribed and trans-
lated in an in vitro system suggesting that the lower band
should be a product of posttranslational processing (Fig. 4C).
Similar results have been previously reported for RBP63 from
Crithidia fasciculata [28] where two polypeptides of 56 and
48 kDa, degradation products of the RBP63 protein processed
near the C-terminal end, are observed. Breakdown products are
also observed during the puriﬁcation of PABPs from other kine-
toplastides [12,13,29].
Finally, for further characterization of LiPABP, we have checked
the ability of p38 MAPK to phosphorylate LiPABP, as occurs for hu-
man PABP [30]. As shown in Fig. 4D, LiPABP is substrate of p38
MAPK. The analysis of the LiPABP sequence identiﬁes a potential
p38 MAPK phosphorylation site in the C-terminal domain of the
protein that is also present in human PABP. It has been described
that p38 MAPK phosphorylation of human PABP plays some role
in RNA deadenylation [30].epresentative blots showing the amount of endogenous LiPABP (A) or myc-LiPABP
f free poly(A) or poly(U) competitors are shown at the top of the ﬁgures. Input
-LiPABP was loaded in parallel. Bands were quantiﬁed as described in Section 2 and
represent the mean ± S.E.M. of three different experiments. Statistical signiﬁcance:
ed and translated in vitro were blotted with anti-myc (Santa Cruz Tech.) antibody
HEK293T cells previously transfected with pcDNA3-myc-LiPABP was loaded in the
kinase assay. Autoradiography (top) and Coomassie staining (bottom) are shown.
control. A putative p38 MAPK phosphorylation site located in the LiPABP sequence,
arks a putative degradation product in panels B and C.
198 N. Guerra et al. / FEBS Letters 585 (2011) 193–198In conclusion, we described a PABP homologue from L. infantum,
named LiPABP, that contains the main domains present in PABPs
from other organisms, maintains poly(A) binding capability and
is phosphorylated by p38 MAPK. Furthermore, the expression of
endogenous LiPABP is conﬁrmed by sera from dogs with canine VL.
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